Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its target price increased by equities research analysts at HC ...
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) shares hit a new 52-week high during trading on Friday after HC Wainwright raised their price target on the stock from $190.00 to $200.00. HC ...
22h
Investor's Business Daily on MSNThese Biotech Stocks Aren't Profitable But Still Make Elite IBD 50A handful of biotech stocks made an elite list despite being unprofitable. But many show robust sales growth and constructive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results